Paper24322971
Cardiovascular pharmacogenomics: expectations and practical benefits.
Turner RM and 1 other. Clin Pharmacol Ther, 2014. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Cardiovascular pharmacogenomics: expectations and practical benefits. Papers, record 24322971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24322971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Pharmacogenetics | Major topic |
| Adrenergic beta-Antagonists | |
| Animals | |
| Anti-Arrhythmia Agents | |
| Anticoagulants | |
| Clopidogrel | |
| Humans | |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
| Platelet Aggregation Inhibitors | |
| Renin-Angiotensin System | |
| Ticlopidine | |
| Warfarin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/L006758/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42722881 | Real-world pharmacogenomics-guided antihypertensive treatment response in clinical practice underrepresented population: implications for precision prescribing and medication safety. | Eur J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42722881 | PubMed |
| 42563500 | Operationalizing Precision Medicine in Drug Development: Predictive Biomarkers, Companion Diagnostics, and Regulatory Pathways. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42563500 | PubMed |
| 42115787 | Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42115787 | PubMed |
| 38420192 | From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38420192 | PubMed |
| 35444556 | Ethnic Diversity and Warfarin Pharmacogenomics. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35444556 | PubMed |
| 34682891 | The Person's Care Requires a Sex and Gender Approach. | J Clin Med | 2021 | https://conductscience.org/library/papers/34682891 | PubMed |
| 34451827 | Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile? | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34451827 | PubMed |
| 33638977 | The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. | Eur Heart J Cardiovasc Pharmacother | 2022 | https://conductscience.org/library/papers/33638977 | PubMed |
| 33528719 | The Interface of Therapeutics and Genomics in Cardiovascular Medicine. | Cardiovasc Drugs Ther | 2021 | https://conductscience.org/library/papers/33528719 | PubMed |
| 33198260 | Pharmacogenomics for Primary Care: An Overview. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/33198260 | PubMed |
| 33143137 | A Review of the Important Role of CYP2D6 in Pharmacogenomics. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/33143137 | PubMed |
| 33080066 | Warfarin dosing algorithms: A systematic review. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33080066 | PubMed |
| 31772608 | Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome. | Cardiovasc Ther | 2019 | https://conductscience.org/library/papers/31772608 | PubMed |
| 30005242 | Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort. | J Pharm Biomed Anal | 2018 | https://conductscience.org/library/papers/30005242 | PubMed |
| 28944433 | Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies. | Curr Atheroscler Rep | 2017 | https://conductscience.org/library/papers/28944433 | PubMed |
| 28431457 | Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not? | Addiction | 2017 | https://conductscience.org/library/papers/28431457 | PubMed |
| 28357786 | The Real Role of β-Blockers in Daily Cardiovascular Therapy. | Am J Cardiovasc Drugs | 2017 | https://conductscience.org/library/papers/28357786 | PubMed |
| 27280306 | Contextualizing Genetics for Regional Heart Failure Care. | Curr Cardiol Rev | 2016 | https://conductscience.org/library/papers/27280306 | PubMed |
| 26835069 | Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice. | Arrhythm Electrophysiol Rev | 2014 | https://conductscience.org/library/papers/26835069 | PubMed |
| 26607661 | SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study. | Sci Rep | 2015 | https://conductscience.org/library/papers/26607661 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADRA2C | 152 | PubTator's text mining | https://conductscience.org/library/genes/152 | NCBI Gene |
| ADRB1 | 153 | PubTator's text mining | https://conductscience.org/library/genes/153 | NCBI Gene |
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 | NCBI Gene |
| CYP2C9 | 1559 | PubTator's text mining | https://conductscience.org/library/genes/1559 | NCBI Gene |
| CYP4F2 | 8529 | PubTator's text mining | https://conductscience.org/library/genes/8529 | NCBI Gene |
| SLCO1B1 | 10599 | PubTator's text mining | https://conductscience.org/library/genes/10599 | NCBI Gene |
| VKORC1 | 79001 | PubTator's text mining | https://conductscience.org/library/genes/79001 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24322971
GET https://conductscience.org/api/papers/v1/24322971/cited_by?page=2